Literature DB >> 7370255

Effects of vanadate in cultured rat heart muscle cells. Vanadate transport, intracellular binding and vanadate-induced changes in beating and in active cation flux.

K Werdan, G Bauriedel, M Bozsik, W Krawietz, E Erdmann.   

Abstract

Cultured rat heart muscle cells have been used to study uptake and intracellular binding of Na483VO4 (vanadate), as well as the influence of vanadate on beating and 86Rb+ uptake of these cells. 1. Vanadate is taken up into cultured rat heart muscle cells in an energy-independent manner by a saturable transport system (Km approximately 60 microM, V approximately 200 pmol per mg protein per min at 37 degrees C). Analysis of intracellular binding of vanadate reveals a curved Scatchard plot indicating more than one binding site. Maximal binding amounts to 3 . 10(9) molecules of vanadate per cell. 2. Vanadate exerts a positive chronotropic and inotropic effect and increases automaticity. First effects can be seen at 1 . 10(-7) M Na3VO4. Concentrations higher than 1. 10(-3) M induce toxic effects (arrhythmias, fibrillation and stand-still of the cell). 3. Vanadate-induced alterations of beating is paralleled by a vanadate-induced stimulation of (86Rb+ + K+) uptake into the cells of up to 75%. Maximal stimulation is obtained at concentrations of 1 . 10(-4)--1 . 10(-3) M vanadate. The stimulation is thought to be due to an increased activity of (Na+ + K+)-ATPase, since it can be inhibited by ouabain. This result is in contrast to in vitro experiments with purified membrane preparations of (Na+ + K+)-ATPase of different organs, where an inhibition of (Na+ + K+)-ATPase by vanadate has been found. 4. The results indicate a possible role of vanadate as an endogenous regulator of active cation flux in heart tissue.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7370255     DOI: 10.1016/0005-2736(80)90113-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  17 in total

1.  Cardiac glycoside tolerance in cultured chicken heart muscle cells--a dose-dependent phenomenon.

Authors:  K Werdan; C Reithmann; E Erdmann
Journal:  Klin Wochenschr       Date:  1985-12-16

2.  Modification of single cardiac Na+ channels by DPI 201-106.

Authors:  M Kohlhardt; U Fröbe; J W Herzig
Journal:  J Membr Biol       Date:  1986       Impact factor: 1.843

3.  Opioids stimulate sarcolemmal NAD(P)H-vanadate dehydrogenase activity.

Authors:  C Ventura; C Guarnieri; L Bastagli; C M Caldarera
Journal:  Basic Res Cardiol       Date:  1988 Jul-Aug       Impact factor: 17.165

4.  Modulation of Na+,K(+)-ATPase activity by a tyrosine phosphorylation process in rat proximal convoluted tubule.

Authors:  E Féraille; M L Carranza; M Rousselot; H Favre
Journal:  J Physiol       Date:  1997-01-01       Impact factor: 5.182

5.  The red blood cell: a model for ouabain receptor regulation in the heart?

Authors:  L Brown; K Werdan; E Erdmann
Journal:  Klin Wochenschr       Date:  1986-09-01

6.  Stimulation of human cardiac adenylate cyclase by vanadate.

Authors:  W Krawietz; K Werdan; E Erdmann
Journal:  Basic Res Cardiol       Date:  1980 May-Jun       Impact factor: 17.165

7.  Vanadate stimulates the pumped movements of Na in skeletal muscle.

Authors:  D Erlij
Journal:  Pflugers Arch       Date:  1984-04       Impact factor: 3.657

8.  Significance of NADH-vanadate-oxidoreductase of cardiac and erythrocyte cell membranes.

Authors:  E Erdmann; K Werdan; W Krawietz; M Lebuhn; S Christl
Journal:  Basic Res Cardiol       Date:  1980 May-Jun       Impact factor: 17.165

9.  Possible mechanisms for inotropic actions of vanadate in isolated guinea pig and rat heart preparations.

Authors:  K Takeda; T Akera; S Yamamoto; I S Shieh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-11       Impact factor: 3.000

10.  Regulation of active cation flux by vanadate in beating rat heart muscle cells in culture.

Authors:  K Werdan; G Bauriedel; M Bozsik; W Krawietz; E Erdmann
Journal:  Basic Res Cardiol       Date:  1980 May-Jun       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.